CHM's Future, page-10

First 10 Last

Share
Profile

Follow
abitlikeme

7,316 Posts.

287

07/06/24

22:40

Post #: 74225193
Share

Originally posted by Steini: ↑

If the data will be as good as the ph1 read out or better then it could be worth in the USD billions. It all depends on how much better than the current treatments and how quickly it could get FDA approved. Definitely more than what the MC currently is, and that includes CDH 17 and NK-platform.

ALA went again upwards and still not an IND, their MC now 135m, EV 125m, about 12-15x that of CHM's EV. And again, what have they got or achieved?

The difference is a management that is actively persuading investors that their iNKT is the best thing since sliced bread based on pre-clinicals. They target liquid cancers such as blood and skin, an already saturated cell therapy field covering about 10% of all cancers. CHM's NK are in the same group but already great data on the score book and if the current AML trial works out as expected then there is a fast approval possible.

CDH17 targets 90% of all cancers and so far, apart of IMU's CF33 / CD19 combo, there is no direct solid cancer CAR-T out there and CDH17 is about to get into the first patients any day. Again, why is the market considering ALA's 101 as gold and everything CHM got as crap. Doesn't make sense unless someone deliberately talks and CapRaises the company down. Who could that be? Steini?

GLTA

Expand

Im afraid you have no idea about ALA, i actually picked up another 500k today at 13.

But yes CHM is ridiculously under valued.

CHM Price at posting: 1.7¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

ZNC

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

The iron ore comeback: Can it last?

HAS

Hastings progressing Yangibana to production with lower costs

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 13 more messages in this thread...

First 10 Last

Add CHM (ASX) to my watchlist

(20min delay)
Last 1.4¢		Change 0.000(0.00%)		Mkt cap ! $12.67M

Open	High	Low	Value	Volume
1.4¢	1.5¢	1.4¢	$14.47K	1.027M

Buyers (Bids)

No.	Vol.	Price($)
1	391724	1.4¢

Sellers (Offers)

Price($)	Vol.	No.
1.5¢	579596	1

View Market Depth

No.	Vol.	Price($)
1	391724	0.014
13	3124769	0.013
8	1386816	0.012
3	672817	0.011
4	485142	0.010

Price($)	Vol.	No.
0.015	579596	1
0.016	735854	3
0.017	647827	3
0.018	1788235	5
0.019	987804	3

Last trade - 16.10pm 30/09/2024 (20 minute delay)

CHM (ASX) Chart

CHM's Future, page-10

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

The iron ore comeback: Can it last?

Hastings progressing Yangibana to production with lower costs

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

CHM's Future, page-10

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Zenith's sale of Develin Creek delivers $975K cash, with shares up 13%

The iron ore comeback: Can it last?

Hastings progressing Yangibana to production with lower costs

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News